From Trauma to Transformation: Tania De Jong's Mission to Revolutionize Mental Health
August 24, 2026 · 44 min
Why listen
Find out how Australia became the first country to federally legalize MDMA and psilocybin for clinical psychiatry.
Enjoy the episode?
Subscribe to The Psychedelic Report
In this episode
- The policy steps that led to Australia's historic rescheduling decision
- Why clinician training and integration matter as much as the medicine itself
- How personal trauma shaped one advocate's mission to reform mental healthcare
- What other countries can realistically learn from Australia's regulatory model
About this episode
What does it take to change an entire country's approach to mental healthcare?
In this episode of The Psychedelic Report, Dr. Dave Rabin sits down with entrepreneur, singer, and Mind Medicine Australia co-founder Tania De Jong to explore how Australia became the first country to federally reschedule MDMA and psilocybin for clinical use in psychiatry. Tania shares her deeply personal journey into psychedelic medicine, inspired by her family's Holocaust history, her own healing experiences, and a mission to make transformative therapies accessible to people living with treatment-resistant mental illness.
Together, Dave and Tania discuss the science behind psychedelic-assisted therapy, why clinician training and integration are just as important as the medicines themselves, and the lessons the rest of the world can learn from Australia's groundbreaking model. They also examine the global mental health crisis, the promise of psychedelic medicine for trauma and depression, and what it will take to bring these treatments safely to more people.
If you're curious about the future of mental healthcare, this conversation offers an inside look at one of the most significant shifts happening in medicine today.
Web: https://www.medicinesaustralia.com.au/
Instagram: https://www.instagram.com/taniadejongam
Web: https://thepsychedelic.report
Instagram: https://www.instagram.com/drdavidrabin
X: https://twitter.com/DrDavidRabin
More from Dr. Dave: https://www.drdave.io/
Learn more about your ad choices. Visit megaphone.fm/adchoices
About The Psychedelic Report
Dr. Dave Rabin MD, PhD, a psychiatrist and neuroscientist trained in Ketamine and MDMA-assisted therapy, brings you the newest developments from the world of psychedelic science and technology. From researchers and investors to physicians and shamans to nonprofit pioneers and policy-makers — each week, Dr.
See all episodes →
